JULIE SHAHEEN: Open Payments
NPI 1578019717 · CHARLESTON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,998 in 108 payments from 19 companies in 2025. Trend: 2023 $1,261 · 2024 $2,131 · 2025 $1,998
Food & beverage: $1,998
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 26 | $298 |
| Novartis Pharmaceuticals Corporation | 9 | $229 |
| GENZYME CORPORATION | 9 | $212 |
| Incyte Corporation | 7 | $159 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 8 | $154 |
| Arcutis Biotherapeutics, Inc. | 3 | $154 |
| ABBVIE INC. | 10 | $136 |
| Regeneron Healthcare Solutions, Inc. | 5 | $100 |
| Janssen Biotech, Inc. | 6 | $100 |
| Organon LLC | 6 | $90 |
Products named: DUPIXENT, NEMLUVIO, COSENTYX, OPZELURA, Zoryve, TREMFYA, ILUMYA, RINVOQ.
Industry payments across SC — which companies pay providers there.
